Hexagon Nutrition Limited (NSE: HEXAGON, BSE: 544785) is a #INVALID COMPANY ID-based company in the Vitamins and Nutritional Supplements industry. With a market capitalisation of ₹737 Cr, it ranks #1,768 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 5 in Vitamins and Nutritional Supplements. At ₹58.72 (as of 16 Nov 2026), the share price is 25.0% below its 52-week high of ₹78.25 and 22.1% above its 52-week low of ₹48.10.
| Current Price | ₹58.72 |
|---|---|
| Market Cap | ₹737 Cr |
| NSE Symbol | HEXAGON |
| BSE Code | 544785 |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Vitamins and Nutritional Supplements |
| P/E Ratio | 19.4 |
| Return on Equity | 16.26% |
| Return on Assets | 9.33% |
| 52-Week Range | ₹48.10 – ₹78.25 |
| 3-Month Price Change | -8.9% |
| Beta (1Y) | 0.08 |
| Dividend Yield | 0.50% |
| Headquarters | #INVALID COMPANY ID |
| Website | hexagonnutrition.com |
| Revenue | ₹110 Cr |
|---|---|
| Net Profit | ₹8 Cr |
| Net Margin | 7.4% |
| EPS (Basic) | ₹0.74 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Hexagon Nutrition Limited reported revenue of ₹110 Cr in Q2 FY27, up 5.1% from ₹104 Cr in Q1 FY27. It posted a net profit of ₹8 Cr for the quarter, against a net profit of ₹8 Cr in Q1 FY27 (up 1.1%).
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹110 Cr | ₹8 Cr | 7.4% |
| Q1 FY27 | ₹104 Cr | ₹8 Cr | 7.7% |
| Q4 FY26 | ₹115 Cr | ₹11 Cr | 9.5% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 64.36% of Hexagon Nutrition Limited's shares as of Sept 2026, against 64.29% in Jun 2026 (+0.07 percentage points). Delivery averaged 56.3% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Hexagon Nutrition Limited operates as a nutraceutical business focused on the development and supply of micronutrient premixes, clinical nutrition, and therapeutic food in India and South Africa, Malaysia, Ethiopia, France, French Polynesia, Ghana, Indonesia, Kenya, Madagascar, Mozambique, Papua New Guinea, Nigeria, Philippines, Qatar, UAE, Mauritius, Brazil, Bangladesh, Rwanda, and Internationally. The company provides ready-to-use supplementary food (RUSF), ready-to-use therapeutic food (RUTF), health and wellness products, and home fortification solutions. It also develops functional foods, dietary supplements, plant-based nutritional alternatives, maternal and geriatric nutrition products, and condition-specific formulations aimed at managing lifestyle disorders, such as diabetes, cardiovascular health, and obesity. It serves food companies and nutraceutical industry. The company was founded in 1991 and is headquartered in Mumbai, India.
1. Vitamins & Nutrition Products-This segment engages in the manufacturing and trading of nutraceuticals clinical or dietary supplements, micronutrient premixes, and animal feed. 2. NA-NA 3. NA-NA 4. NA-NA
1. Nutraceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Hexagon Nutrition Limited | ₹737 Cr | 19.4 | 16.26% | ₹110 Cr | — |
| Aayush Food And Herbs Ltd | ₹144 Cr | 36.4 | 38.75% | — | -67.8% |
| Sandu Pharmaceuticals Ltd. | ₹37 Cr | 20.7 | 4.13% | ₹16 Cr | -12.8% |
| Deccan Health Care Ltd | ₹28 Cr | 11.9 | 2.11% | ₹22 Cr | -30.1% |
| Walpar Nutritions Limited | ₹23 Cr | 9.2 | 13.93% | — | -47.4% |
Listed by market capitalisation. Ratios are shown for context only.
Hexagon Nutrition Limited is trading at ₹58.72, with a market capitalisation of ₹737 Cr.
Hexagon Nutrition Limited operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Vitamins and Nutritional Supplements).
Hexagon Nutrition Limited has a P/E of 19.4 and a return on equity of 16.26%.
Hexagon Nutrition Limited is listed on the NSE under the symbol HEXAGON and on the BSE under the scrip code 544785.
In Q2 FY27, Hexagon Nutrition Limited reported revenue of ₹110 Cr and net profit of ₹8 Cr, with basic EPS of ₹0.74 (consolidated, parsed from the company's exchange filing).
Promoters held 64.36% of Hexagon Nutrition Limited's shares as of Sept 2026, against 64.29% in Jun 2026 (+0.07 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.